Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: GlobalData | PRODUCT CODE: 1345181

Cover Image

PUBLISHER: GlobalData | PRODUCT CODE: 1345181

Minimal Invasive Spinal Devices Pipeline Report Including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update

PUBLISHED:
PAGES:
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 4000
PDF (Site License)
USD 8000
PDF (Global License)
USD 12000

Add to Cart

Abstract

GlobalData's Medical Devices sector report, "Minimal Invasive Spinal Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update" provides comprehensive information about the Minimal Invasive Spinal Devices pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Minimally Invasive Spine (MIS) fusion surgery is performed to stabilize the vertebral bones and joints using devices such as Cannulated and non-Cannulated screws.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Minimal Invasive Spinal Devices under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Minimal Invasive Spinal Devices and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to Buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Minimal Invasive Spinal Devices under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date
Product Code: GDME1608EPD

Table of Contents

1 Table of Contents

  • 1.1 List of Tables
  • 1.2 List of Figures

2 Introduction

  • 2.1 Minimal Invasive Spinal Devices Overview

3 Products under Development

  • 3.1 Minimal Invasive Spinal Devices - Pipeline Products by Stage of Development
  • 3.2 Minimal Invasive Spinal Devices - Pipeline Products by Segment
  • 3.3 Minimal Invasive Spinal Devices - Pipeline Products by Territory
  • 3.4 Minimal Invasive Spinal Devices - Pipeline Products by Regulatory Path
  • 3.5 Minimal Invasive Spinal Devices - Pipeline Products by Estimated Approval Date
  • 3.6 Minimal Invasive Spinal Devices - Ongoing Clinical Trials

4 Minimal Invasive Spinal Devices - Pipeline Products under Development by Companies

  • 4.1 Minimal Invasive Spinal Devices Companies - Pipeline Products by Stage of Development
  • 4.2 Minimal Invasive Spinal Devices - Pipeline Products by Stage of Development

5 Minimal Invasive Spinal Devices Companies and Product Overview

6 Minimal Invasive Spinal Devices- Recent Developments

  • 6.1 Jul 05, 2023: Inspired Spine Hosts Third International Lab in Germany, Showcasing OLLIF and Trident SI Joint Fusion Procedures
  • 6.2 May 23, 2023: Aurora Spine schedules release of Q1 fiscal year 2023 financial results and conference call
  • 6.3 Apr 26, 2023: Aurora Spine schedules release of Q4 and fiscal year 2022 financial results and conference call
  • 6.4 Feb 16, 2023: Lazurite Names Physicians to Medical Advisory Board
  • 6.5 Nov 21, 2022: Aurora Spine Announces Third Quarter Fiscal 2022 Financial Results
  • 6.6 Oct 12, 2022: Aurora Spine Corporation to Attend the North American Spine Society Annual Meeting

7 Appendix

  • 7.1 Methodology
  • 7.2 About GlobalData
  • 7.3 Contact Us
  • 7.4 Disclaimer
Product Code: GDME1608EPD

List of Tables

List of Tables

  • Minimal Invasive Spinal Devices - Pipeline Products by Stage of Development
  • Minimal Invasive Spinal Devices - Pipeline Products by Segment
  • Minimal Invasive Spinal Devices - Pipeline Products by Territory
  • Minimal Invasive Spinal Devices - Pipeline Products by Regulatory Path
  • Minimal Invasive Spinal Devices - Pipeline Products by Estimated Approval Date
  • Minimal Invasive Spinal Devices - Ongoing Clinical Trials
  • Minimal Invasive Spinal Devices Companies - Pipeline Products by Stage of Development
  • Minimal Invasive Spinal Devices - Pipeline Products by Stage of Development
  • Glossary

List of Figures

List of Figures

  • Minimal Invasive Spinal Devices - Pipeline Products by Stage of Development
  • Minimal Invasive Spinal Devices - Pipeline Products by Segment
  • Minimal Invasive Spinal Devices - Pipeline Products by Territory
  • Minimal Invasive Spinal Devices - Pipeline Products by Regulatory Path
  • Minimal Invasive Spinal Devices - Pipeline Products by Estimated Approval Date
  • Minimal Invasive Spinal Devices - Ongoing Clinical Trials
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!